我欲封天txt下载,管理书籍排行榜

肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體

Western Blot; Sample: Human Saliva Primary Ab: 2μg/ml Mouse Anti-Human PADI4 Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)

該抗體是針對(duì)PADI4的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別PADI4。

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。

雜志	參考文獻(xiàn)
Arthritis Res Ther.	Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility [Pubmed:Pmc4229860]
Journal of Molecular?Cell?Biology	Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients [Pubmed:30044533]
Journal of Inflammation Research	Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery [Pubmed: 31213874]
Revista da Associacao Medica Brasileira	Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury []

留言咨詢

編號(hào)	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPF709Hu01	肽基精氨酸脫亞氨酶Ⅳ(PADI4)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAF709Hu01	肽基精氨酸脫亞氨酶Ⅳ(PADI4)多克隆抗體	WB; IHC; ICC; IP.
MAF709Hu21	肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體	WB
MAF709Hu22	肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體	WB; IHC; ICC; IP.
MAF709Hu23	肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體	WB; IHC; ICC; IP.
MAF709Hu24	肽基精氨酸脫亞氨酶Ⅳ(PADI4)單克隆抗體	WB; IHC; ICC; IP.
SEF709Hu	肽基精氨酸脫亞氨酶Ⅳ(PADI4)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
LMF709Hu	肽基精氨酸脫亞氨酶Ⅳ(PADI4)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.